A citation-based method for searching scientific literature

Leigha Senter, David M O'Malley, Floor J Backes, Larry J Copeland, Jeffery M Fowler, Ritu Salani, David E Cohn. Gynecol Oncol 2017
Times Cited: 17







List of co-cited articles
83 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
122
52

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
52
52

A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Erica M Bednar, Holly D Oakley, Charlotte C Sun, Catherine C Burke, Mark F Munsell, Shannon N Westin, Karen H Lu. Gynecol Oncol 2017
24
47

Impact of an embedded genetic counselor on breast cancer treatment.
Holly J Pederson, Najaah Hussain, Ryan Noss, Courtney Yanda, Colin O'Rourke, Charis Eng, Stephen R Grobmyer. Breast Cancer Res Treat 2018
15
46

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
310
35

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
91
35

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
58
29

Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
R Demsky, J McCuaig, M Maganti, K J Murphy, B Rosen, S R Armel. Gynecol Oncol 2013
36
29

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Leslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, John P Diaz, Adam Buchanan, Catherine T Witkop, C Bethan Powell, Ellen Blair Smith, Mark E Robson, Jeff Boyd,[...]. Gynecol Oncol 2017
47
29

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
139
29

The sooner the better: Genetic testing following ovarian cancer diagnosis.
E Fox, J McCuaig, R Demsky, C Shuman, D Chitayat, M Maganti, J Murphy, B Rosen, S Ferguson, S Randall Armel. Gynecol Oncol 2015
16
25

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
C Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman. Int J Gynecol Cancer 2013
33
23

Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force.
Stephanie A Cohen, Monica L Marvin, Bronson D Riley, Hetal S Vig, Julie A Rousseau, Shanna L Gustafson. J Genet Couns 2013
72
23


BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
638
23

Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario.
Jacob McGee, Karen Panabaker, Sean Leonard, Peter Ainsworth, Laurie Elit, Salimah Z Shariff. Int J Gynecol Cancer 2017
14
28

Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
72
23

Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system.
Sue V Petzel, Rachel Isaksson Vogel, Jena McNiel, Anna Leininger, Peter A Argenta, Melissa A Geller. Int J Gynecol Cancer 2014
18
17

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Johnathan M Lancaster, C Bethan Powell, Lee-May Chen, Debra L Richardson. Gynecol Oncol 2015
141
17

Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
Sue V Petzel, Rachel Isaksson Vogel, Tracy Bensend, Anna Leininger, Peter A Argenta, Melissa A Geller. J Genet Couns 2013
28
17


Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
Paul A Cohen, Cassandra B Nichols, Lyn Schofield, Steven Van Der Werf, Nicholas Pachter. Int J Gynecol Cancer 2016
14
21

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
699
17

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
39
17

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen, Harvey A Risch, Isabel Fan, Linda Bradley, Patricia A Shaw, Steven A Narod. Gynecol Oncol 2011
220
17

The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine.
Katie Stoll, Shobana Kubendran, Stephanie A Cohen. Am J Med Genet C Semin Med Genet 2018
45
17

Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Jaclyn C Watkins, Eric J Yang, Michael G Muto, Colleen M Feltmate, Ross S Berkowitz, Neil S Horowitz, Sapna Syngal, Matthew B Yurgelun, Anu Chittenden, Jason L Hornick,[...]. Int J Gynecol Pathol 2017
47
17

Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
.
Danielle M Fournier, Angela F Bazzell, Joyce E Dains. Oncol Nurs Forum 2018
13
23

Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Anita Y Kinney, Karin M Butler, Marc D Schwartz, Jeanne S Mandelblatt, Kenneth M Boucher, Lisa M Pappas, Amanda Gammon, Wendy Kohlmann, Sandra L Edwards, Antoinette M Stroup,[...]. J Natl Cancer Inst 2014
70
17

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
99
17

There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
B Meiser, M Gleeson, N Kasparian, K Barlow-Stewart, M Ryan, K Watts, D Menon, G Mitchell, K Tucker. Gynecol Oncol 2012
29
11

Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Kasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, Samantha Hansford, Sean Young, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Obstet Gynecol 2012
80
11

Poly (ADP-ribose) polymerase inhibitors: recent advances and future development.
Clare L Scott, Elizabeth M Swisher, Scott H Kaufmann. J Clin Oncol 2015
218
11

A systematic review of factors that act as barriers to patient referral to genetic services.
Türem Delikurt, Graham R Williamson, Violetta Anastasiadou, Heather Skirton. Eur J Hum Genet 2015
65
11

Improving attendance to genetic counselling services for gynaecological oncology patients.
Hanoon P Pokharel, Neville F Hacker, Lesley Andrews. Gynecol Oncol Res Pract 2018
2
100

Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
62
11

Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.
Akiva P Novetsky, Kylie Smith, Sheri A Babb, Donna B Jeffe, Andrea R Hagemann, Premal H Thaker, Matthew A Powell, David G Mutch, L Stewart Massad, Israel Zighelboim. Int J Gynecol Cancer 2013
10
20

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
42
11

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
74
11

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
T Pal, J-H Lee, A Besharat, Z Thompson, A N A Monteiro, C Phelan, J M Lancaster, K Metcalfe, T A Sellers, S Vadaparampil,[...]. Clin Genet 2014
22
11

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
97
11

Adverse events in cancer genetic testing: the third case series.
Danielle C Bonadies, Karina L Brierley, Rachel E Barnett, Melanie D Baxter, Talia Donenberg, Whitney L Ducaine, Michelle E Ernst, Jeanne Homer, Megan Judkins, Niki M Lovick,[...]. Cancer J 2014
24
11

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
56
11

Errors in delivery of cancer genetics services: implications for practice.
Karina L Brierley, Danielle Campfield, Whitney Ducaine, Lindsay Dohany, Talia Donenberg, Kristen Shannon, Robin C Schwartz, Ellen T Matloff. Conn Med 2010
63
11

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
Gillian E Hanley, Jessica N McAlpine, Dianne Miller, David Huntsman, Kasmintan A Schrader, C Blake Gilks, Gillian Mitchell. BMC Cancer 2018
8
25

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Bent E Fiane, Turid Aas, Kathrine Woie, Helge Espelid, Tone Rusken, Hans Petter Eikesdal, Wenche Listøl, Marianne T Haavind,[...]. Eur J Hum Genet 2016
34
11

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
Aisha S Sie, Wendy A G van Zelst-Stams, Liesbeth Spruijt, Arjen R Mensenkamp, Marjolijn J L Ligtenberg, Han G Brunner, Judith B Prins, Nicoline Hoogerbrugge. Fam Cancer 2014
30
11

The value of a genetic counselor: improving identification of cancer genetic counseling patients with chart review.
Jennifer N Eichmeyer, Christa Burnham, Patty Sproat, Rick Tivis, Thomas M Beck. J Genet Couns 2014
10
20

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.
Jeanna M McCuaig, Tracy L Stockley, Patricia Shaw, Michael Fung-Kee-Fung, Alon D Altman, James Bentley, Marcus Q Bernardini, Beatrice Cormier, Hal Hirte, Katharina Kieser,[...]. J Med Genet 2018
16
12

New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.
Inga Plaskocinska, Hannah Shipman, James Drummond, Edward Thompson, Vanessa Buchanan, Barbara Newcombe, Charlotte Hodgkin, Elisa Barter, Paul Ridley, Rita Ng,[...]. J Med Genet 2016
31
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.